NMPA Approval

Insulin Aspart 30 Injection

Approval Number

S20140060

Registration Date

August 8, 2019

Previous Approval Numbers

S20140060

Drug Information

Generic Name

门冬胰岛素30注射液

Trade Name

诺和锐30

Brand Name

诺和锐

Dosage Form

注射剂

Strength

100单位/毫升,3毫升/支(特充)

Drug Type

生物制品

Registration Date

August 8, 2019

Expiry Date

August 7, 2024

Company Address

Novo Alle, DK-2880 Bagsvaerd, Denmark

Company Address

Novo Alle, DK-2880 Bagsvaerd

Empowering clinical research with data-driven insights and AI-powered tools.